Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens-Reference-Cited by-同舟云学术

Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens

Author:

Hussein Maytham^ORCID,Hu Xiaohan,Paulin Olivia K.A.,Crawford Simon,Tony Zhou Qi,Baker Mark,Schneider-Futschik Elena K.,Zhu Yan,Li Jian,Velkov Tony

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference51 articles.

1. WHO. Antimicrobial resistance: global report on surveillance 2014. 2014.

2. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics;Organization,2017

4. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE;Rice,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献